Products for Research Use Only

SLC7A11-IN-1

CAT: 0804-HY-149979-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-149979-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SLC7A11-IN-1 is a potent solute carrier family 7 member 11 (SLC7A11, xCT) inhibitor. SLC7A11-IN-1 shows antiproliferative activity. SLC7A11-IN-1 inhibits cell invasion and metastasis. SLC7A11-IN-1 induces Apoptosis and cell cycle arrest at S-phase. SLC7A11-IN-1 shows anti-tumor activity[1].
CAS Number
3049302-90-8
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/slc7a11-in-1.html
Purity
97.06
Solubility
DMSO : ≥ 20 mg/mL
Smiles
[NH3][Pt+4]([OH-])([Cl-])([Cl-])([O-]C(CCCC(NC1=NC2=CC=C(C=C2S1)OC(F)(F)F)=O)=O)[NH3]
Molecular Formula
C13H17Cl2F3N4O5PtS
Molecular Weight
664.35
References & Citations
[1]Li Z, et al. Blocking xCT and PI3K/Akt pathway synergized with DNA damage of Riluzole-Pt (IV) prodrugs for cancer treatment. Eur J Med Chem. 2023 Mar 15;250:115233.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported